NAM
ONCS

Nexpoint Asset Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Nexpoint Asset Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,409
Closed -$72K – 246
2021
Q4 		$72K Sell
3,409
-10,965
-76% -$371K 0.01% 206
2021
Q3 		$674K Buy
+14,374
New +$728K 0.12% 89

Other funds holding ONCS

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Nexpoint Asset Management's ONCS Position: Q1 2022 in Review

Nexpoint Asset Management sold out of OncoSec Medical Incorporated (ONCS) in Q1 2022, closing a stake of 3,409 shares — an estimated $72K sold.

Nexpoint Asset Management first reported a position in ONCS in Q3 2021 and held it in 2 quarters. The position peaked at $674K in Q3 2021. 28 funds tracked by Wall St. Rank hold ONCS as of Q1 2022.

  • Nexpoint Asset Management reported no remaining OncoSec Medical Incorporated position as of Q1 2022 after selling out during the quarter.
  • Nexpoint Asset Management sold 3,409 OncoSec Medical Incorporated shares in Q1 2022, an estimated $72K.
  • Nexpoint Asset Management first reported a position in OncoSec Medical Incorporated in Q3 2021 and held it in 2 quarters.
  • Nexpoint Asset Management's OncoSec Medical Incorporated position peaked at $674K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2022.

Based on Nexpoint Asset Management's 13F filing for Q1 2022, filed 16 May 2022.